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Phospholipid ﬂippase ATP11C is endocytosed and
downregulated following Ca2+-mediated protein
kinase C activation
Hiroyuki Takatsu1, Masahiro Takayama1, Tomoki Naito1, Naoto Takada1, Kazuya Tsumagari2,
Yasushi Ishihama 2, Kazuhisa Nakayama 1 & Hye-Won Shin 1
We and others showed that ATP11A and ATP11C, members of the P4-ATPase family,
translocate phosphatidylserine (PS) and phosphatidylethanolamine from the exoplasmic to
the cytoplasmic leaﬂets at the plasma membrane. PS exposure on the outer leaﬂet of the
plasma membrane in activated platelets, erythrocytes, and apoptotic cells was proposed to
require the inhibition of PS-ﬂippases, as well as activation of scramblases. Although ATP11A
and ATP11C are cleaved by caspases in apoptotic cells, it remains unclear how PS-ﬂippase
activity is regulated in non-apoptotic cells. Here we report that the PS-ﬂippase ATP11C, but
not ATP11A, is sequestered from the plasma membrane via clathrin-mediated endocytosis
upon Ca2+-mediated PKC activation. Importantly, we show that a characteristic di-leucine
motif (SVRPLL) in the C-terminal cytoplasmic region of ATP11C becomes functional upon
PKC activation. Moreover endocytosis of ATP11C is induced by Ca2+-signaling via Gq-coupled
receptors. Our data provide the ﬁrst evidence for signal-dependent regulation of mammalian
P4-ATPase.
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Lipid bilayers of cellular membranes exhibit asymmetric lipiddistributions. In mammalian cells, the aminophospholipidsphosphatidylserine (PS) and phosphatidylethanolamine
(PE) are abundant in the cytoplasmic leaﬂet, whereas phospha-
tidylcholine (PC) and sphingomyelin (SM) are enriched in the
exoplasmic leaﬂet of the plasma membrane1–3. Phospholipids are
mostly synthesized on the cytosolic side of the endoplasmic
reticulum (ER) and newly synthesized lipids must be scrambled
across the bilayer to the luminal leaﬂet to avoid the imbalance of
phospholipid mass4, although scrambling proteins in the ER have
not yet been identiﬁed. Phospholipids are distributed throughout
organelle membranes and the plasma membrane, and thus newly
synthesized phospholipids are transported to other organelles via
phospholipid transfer proteins, or via vesicular transport. PS is
synthesized on a region of the ER, called MAM (mitochondria-
associated membranes), and converted to PE in mitochondria5.
PS in the cytosolic leaﬂet of the ER could be transported to the
cytosolic leaﬂet of the plasma membrane by exchange of PS with
phosphatidylinositol 4-phosphate at the ER-plasma membrane
contacts6. PS is also found in the luminal side in earlier secretory
compartments, although PS is mostly distributed in the cytosolic
leaﬂet in late secretory compartments such as the trans-Golgi
network, late endosomes and the plasma membrane7. Since type
IV p-type ATPases (P4-ATPases) translocate aminopho-
spholipids from the exoplasmic/luminal to the cytosolic leaﬂets of
cellular membranes8,9, the presence of P4-ATPases in these
organelles10 is consistent with the asymmetric distribution of
phospholipids in these membranes. PS is ﬂipped to the cytosolic
leaﬂet at the trans-Golgi network by P4-ATPases and the
PS-ﬂipping is required for the secretory vesicular transport11,12.
In addition, PS is abundant in the cytoplasmic side of the plasma
membrane and recycling endosomes7,13,14, and plays important
roles in the recruitment and/or activation of regulatory proteins,
such as protein kinase C (PKC), K-Ras, Cdc42, Rac1, and EHD1,
for signaling, cell polarity, cell migration, and membrane
trafﬁcking14–18.
In previous studies, we showed that the human P4-ATPases
ATP11A and ATP11C localize to the plasma membrane and ﬂip
NBD-labeled PS (NBD-PS) and NBD-PE, whereas ATP8B1,
ATP8B2, and ATP10A ﬂip NBD-PC speciﬁcally at the plasma
membrane9,19,20. We also showed that those P4-ATPases interact
with CDC50A, which is required for their transport from the ER
to the plasma membrane in HeLa cells10,20. ATP11A and
ATP11C are expressed ubiquitously in human and mouse21.
ATP11C is a major PS-ﬂippase in certain cell types such as CHO-
K1 and KBM-7 cells, leukocytes, and erythrocytes19,22–24.
ATP11C deﬁciency causes a defect in B-cell maturation, altered
erythrocyte shape, anemia, and hyperbilirubinemia25–27.
Regulated exposure of PS in the exoplasmic leaﬂet is critical for
several biological processes, including apoptotic cell death, pla-
telet coagulation, fusion of muscle cells, and activation of
lymphocytes28–33. PS exposure during aggregation of platelets is
triggered by a Ca2+-dependent scramblase, TMEM16F, and
its mutation gives rise to Scott syndrome34,35. Ca2+-regulated
exocytosis in neuroendocrine chromafﬁn cells, PC12 cells, and































































Fig. 1 ATP11C is endocytosed by treatment with phorbol 12-myristate 13-acetate (PMA) and increasing cytosolic Ca2+. a HeLa cells stably expressing
C-terminally HA-tagged ATP11A, and ATP11C were treated for 15 min at 37 °C with vehicle alone (Mock); with either 400 nM of PMA (PMA) or PMA and
2 μM of BIM-1 (PMA + BIM); or with 1 μM A23187 in the presence of either 1.8 mM of CaCl2 (A23187) or 1.8 mM CaCl2 and 2 μM BIM-1 (A23187 + BIM).
The cells were ﬁxed and immunostained with anti-HA antibody, followed by Cy3-conjugated anti-rat secondary antibody. See Supplementary Fig. 1 and
Supplementary Movie 1. b Cell-surface expression levels of ATP11A and ATP11C following treatment with PMA or A23187 and CaCl2 were analyzed after
surface biotinylation. Proteins precipitated with streptavidin-agarose beads were subjected to immunoblot analysis (left panels, biotinylated). 15% of the
input of the biotinylation reaction was loaded in each lane (right panels, total lysate). Expression of ATP11A and ATP11C proteins was analyzed by
immunoblotting with anti-HA and anti-ATP1A1 (as an internal control) antibodies. c HeLa cells stably expressing HA-tagged ATP11A and ATP11C, and
parental cells (−) were treated with vehicle alone (white bars), 400 nM of PMA (black bars), or 400 nM of PMA and 2 μM of BIM-1, simultaneously
(gray bars) for 15 min. The cells were then washed with ﬂippase assay buffer and incubated with NBD-PS at 15 °C for 5 min. After extraction with fatty
acid-free BSA, the residual ﬂuorescence intensity associated with the cells was determined by ﬂow cytometry. Fold increase of NBD-PS uptake is shown
relative to that in Mock-treated parental HeLa cells (−). Graph displays averages from four independent experiments± SD. ***p< 0.001
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asymmetry, resulting in the externalization of PS in the outer
leaﬂet of the plasma membrane36. In apoptotic leukocytes, PS
exposure is promoted by the activation of Xkr8, as well as the
inhibition of the PS-ﬂippase ATP11C23,37–39. The increase in
cytosolic Ca2+ level in human erythrocytes inhibits incorporation
of aminophospholipids40, and Ca2+-dependent PKCα activation
mediates PS exposure along with scramblase activation and ﬂip-
pase inhibition41,42. Therefore, regulated exposure of PS might be
accomplished by inhibition of PS-ﬂippases as well as activation of
scramblases, but it remains unclear how the PS-ﬂippase activity is
regulated spatiotemporally in response to speciﬁc signals in living
cells, but not in cells fated for disposal such as activated platelets,
red blood cells, or apoptotic cells.
Here we show that ATP11C is endocytosed following treat-
ment of cells with phorbol ester or an increase in cytosolic Ca2+
level, in HeLa and Ba/F3 cells. ATP11C is also endocytosed
following treatment of cells with serotonin or histamine probably
through Ca2+ signaling via Gq-coupled serotonin or histamine
receptor. Moreover, we reveal a characteristic motif for endocy-
tosis, SVRPLL, which acts as a di-leucine motif ([DE]XXXL[LI])
43,44 upon PKC activation. We further demonstrate that the
signal-responsive endocytosis of ATP11C is important for reg-
ulation of its PS-ﬂippase activity at the plasma membrane.
Results
ATP11C is internalized following PMA treatment or increas-
ing cytosolic Ca2+. Spatiotemporal PS exposure at the plasma
membrane occurs not only in cells fated for disposal, such as
apoptotic cells and activated platelets, but also in many activated
cells, such as lymphocytes, neuroendocrine chromafﬁn cells, and
neurons31–33,36,45. Therefore, there must be a signal-dependent
and spatiotemporal regulation of externalization and inter-
nalization of PS at the plasma membrane. Unexpectedly, we
discovered that ATP11C, a PS-ﬂippase and localizing to the
plasma membrane9 (Fig. 1a and Supplementary Fig. 1, Mock),
was delocalized from the plasma membrane to intracellular
endosomal structures by treatment of HeLa cells stably expressing
HA-tagged ATP11C with phorbol 12-myristate 13-acetate
(PMA), a potent PKC activator (Fig. 1a). Moreover, ATP11C also
localized to intracellular structures following an increase in the
cytosolic Ca2+ level by treatment of cells with a Ca2+ ionophore
A23187 in the presence of extracellular CaCl2, although to a lesser
extent (Fig. 1a). We then investigated whether ATP11A was
delocalized by PMA treatment, because, like ATP11C, it also
localizes to the plasma membrane where it speciﬁcally ﬂips PS
and PE9,10. In marked contrast to the relocalization of ATP11C,
the localization of ATP11A to the plasma membrane was not
altered by PMA or A23187 treatment (Fig. 1a). We also investi-
gated the dynamic localization of other P4-ATPases that localize
to the plasma membrane. As shown in Supplementary Fig. 1,
none of them, except for ATP11C, delocalized from the plasma
membrane by PMA or A23187 treatment. Importantly, the
translocation of ATP11C from the plasma membrane to endo-
somal structures induced by PMA and A23187 was abrogated by
simultaneous treatment with bisindolylmaleimide (BIM)-1, a
PKC-speciﬁc inhibitor, indicating that the translocation of
ATP11C was mediated by Ca2+-dependent PKC activation
(Fig. 1a). We conﬁrmed the level of cell-surface expression of
ATP11C and ATP11A by surface biotinylation analysis. Upon
PMA treatment, the level of ATP11C on the cell surface
decreased, whereas the ATP11A level slightly increased (Fig. 1b).
We then visualized the endocytosis of EGFP-tagged ATP11C in
HeLa cells by time-lapse imaging analysis (Supplementary
Movie 1). EGFP-ATP11C was localized to the plasma membrane
at steady state, but upon treatment with PMA rapidly internalized
and accumulated to endosomal compartments. Together, these
ﬁndings show that ATP11C is endocytosed in response to Ca2
+-dependent PKC activation.
Flippase activity toward PS decreased by PMA in HeLa cells.
We next investigated whether the PS-ﬂippase activity in the




Fig. 2 Internalized ATP11C is localized to early/recycling endosomes. a–c HeLa cells stably expressing C-terminally HA-tagged ATP11C was treated for
15 min with vehicle alone (a), 400 nM PMA (b), or 1 μM A23187 in the presence of 1.8 mM of CaCl2 (c). The cells were ﬁxed and doubly stained for HA
and organelle markers: ATP1A1 (for the plasma membrane); EEA1 (for early endosomes); transferrin receptor (TfnR); VPS35, a component of retromer
complex (for early/recycling endosomes); Lamp-1 (for late endosomes/lysosomes); and TGN46 (for trans-Golgi network). The cells were then incubated
with Cy3-conjugated anti-rat and Alexa Fluor 488-conjugated anti-mouse, anti-rabbit, or anti-goat secondary antibodies. Images (except top and bottom
panels) were obtained by confocal microscopy. Scale bars, 20 μm. Insets are enlarged (bars, 1 μm)
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Incorporation of NBD-PS increased in HeLa cells stably expres-
sing ATP11A and ATP11C, in comparison with the parental cells
(−)9 (Fig. 1c, white bars). Importantly, the PS-ﬂippase activity in
cells expressing ATP11C, but not ATP11A, decreased upon PMA
treatment (Fig. 1c, black bars). Moreover, the reduced NBD-PS
ﬂipping activity was restored by simultaneous treatment of
ATP11C-expressing cells with PMA and BIM-1 (gray bars),
indicating that the inhibition of the PS-ﬂippase activity was
dependent on PKC activation. Because ATP11C, but not
ATP11A, was endocytosed upon PMA treatment (Fig. 1a, b), the
decrease in the PS-ﬂippase activity is attributable to sequestration
of ATP11C from the plasma membrane. Notably, the basal
PS-ﬂippase activity in parental HeLa cells (−) also decreased upon
PMA treatment, potentially due to downregulation of endogen-
ous ATP11C.
Internalized ATP11C localizes to early/recycling endosomes.
To identify the endosomes where ATP11C localizes following
PKC activation, we performed immunostaining for ATP11C
along with several organelle markers such as EEA1 for early
endosomes, transferrin receptor (TfnR), and Vps35 for early/
recycling endosomes, Lamp-1 for late endosomes/lysosomes,
TGN46 for the trans-Golgi network (TGN), and ATP1A1 for the
plasma membrane. PMA treatment increases early endosomal
size46; accordingly, EEA1-, TfnR-, and Vps35-positive structures
slightly increased in size upon treatment of cells with PMA
(Figs. 1a and 2b). ATP11C was extensively colocalized with
ATP1A1 in control cells (Fig. 2a), but hardly colocalized with
ATP1A1 in PMA- or A23187-treated cells (Fig. 2b and c). Fol-
lowing PMA treatment, internalized ATP11C was extensively
colocalized with EEA1, TfnR, and Vps35 (Fig. 2b, enlarged
insets), but minimally colocalized with Lamp-1 (Fig. 2b, enlarged
inset). An increase in cytosolic Ca2+ by A23187 treatment also
caused translocation of ATP11C from the plasma membrane to
early/recycling endosomes (Fig. 2c, enlarged insets), but not to
late endosomes (Fig. 2c, enlarged inset). Although the size of
Mock 5 min 15 min 60 min





Fig. 3 Internalized ATP11C is not transported to late endosomes/lysosomes. a, b HeLa cells stably expressing C-terminally HA-tagged ATP11C was treated
with vehicle alone for 60min (Mock), 400 nM PMA ((a) PMA), or 1 μM A23187 in the presence of 1.8 mM CaCl2 ((b) A23187) for indicated times. The
cells were ﬁxed and doubly stained for HA, and EEA1, TfnR, or Lamp-1, followed by incubation with Cy3-conjugated anti-rat and Alexa Fluor 488-
conjugated anti-mouse secondary antibodies. Images were obtained by confocal microscopy. Scale bars, 20 μm. Insets; bars, 1 μm
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endosomes did not increase, in contrast to their behavior in
PMA-treated cells, the number of small endosomes in cell per-
iphery increased in A23187-treated cells. Internalized ATP11C
was not colocalized with TGN46. Therefore, PKC activation
caused translocation of ATP11C to early/recycling endosomes,
but not to late endosomes.
Next, we examined internalization of ATP11C over a time
course (Fig. 3). ATP11C was localized to EEA1-positive early
endosomes at early time points (5 min) following PMA or
A23187 treatment, suggesting that ATP11C was readily endocy-
tosed upon PKC activation (Fig. 3 and Supplementary Movie 1).
Moreover, internalized ATP11C was not delivered to late
endosomes, but remained in early/recycling endosomes even
after 60 min (insets), suggesting that internalized ATP11C was
not transported to late endosomes/lysosomes for degradation, but
was accumulated at early/recycling endosomes and could
probably be recycled to the plasma membrane (see also Fig. 10d).
C-terminal cytoplasmic region of ATP11C is indispensable for
its PMA-induced endocytosis. P-type ATPases, including yeast
P4-ATPases, possess a regulatory domain in their N- or C-
terminal cytoplasmic region10,47–51. We therefore asked whether
the N- or C-terminal cytoplasmic region of ATP11C is respon-
sible for the PMA-induced endocytosis. To address this question,
we constructed chimeric ATP11A and ATP11C (Fig. 4a and
Supplementary Fig. 2). In the ATP11CAA and ATP11ACC
constructs, the N-terminal cytoplasmic regions of ATP11C and
ATP11A were exchanged, whereas in the ATP11AAC and
ATP11CCA constructs, the C-terminal cytoplasmic regions were
exchanged. We transiently expressed these chimeras in HeLa
cells, and observed their localization following PMA treatment. In
vehicle-treated cells, the chimeras localized to the plasma mem-
brane as efﬁciently as wild-type (WT) ATP11A and ATP11C
(Fig. 4b, Mock). After PMA treatment, ATP11CAA remained
localized to the plasma membrane, whereas ATP11ACC was
endocytosed and localized to endosomes (Fig. 4b). Thus, the N-
terminally exchanged chimeras behaved similarly to WT ATP11A
and ATP11C (Fig. 4b) upon PMA treatment. In striking contrast,
C-terminally exchanged chimeric mutants behaved in an opposite
manner: upon PMA treatment, ATP11AAC was endocytosed and
localized to endosomes, whereas ATP11CCA was not able to
internalize and remained at the plasma membrane (Fig. 4b).
These results revealed that the C-terminal cytoplasmic region of
ATP11C is responsible for the PMA-induced endocytosis.
We next asked whether endocytosis of ATP11C is responsible
for the decrease in its PS-ﬂippase activity at the plasma
membrane and the endocytosis is also observed in other cells.
To this end, we made use of Ba/F3 cells stably expressing
ATP11A, ATP11C, and the ATP11AAC mutant (Fig. 5).
Consistent with the data obtained with HeLa cells, ATP11C
and ATP11AAC were endocytosed upon treatment of Ba/F3 cells
with PMA or A23187 in the presence of extracellular CaCl2 but
ATP11A was not (Fig. 5b, c). We then measured ﬂippase activities
toward NBD-PS, -PE, and -PC after treating cells with PMA or
both PMA and BIM-1. As shown in Fig. 5d–f, cells expressing
ATP11A, ATP11C, and ATP11AAC exhibited elevated ﬂippase
activities toward NBD-PS and NBD-PE, but not NBD-PC, in
comparison with parental Ba/F3 cells (−) (white bars). PS/PE-
ﬂippase activities in ATP11C-expressing cells decreased drama-
tically upon treatment of cells with PMA in comparison with cells
treated with vehicle only (Fig. 5d, e). Importantly, PS/PE-ﬂippase
activities in ATP11AAC-expressing cells also dramatically
decreased after PMA treatment, whereas those of ATP11A-
expressing cells did not change (Fig. 5d, e). Moreover, the reduced
ﬂippase activities of cells expressing ATP11C and ATP11AAC
were restored by simultaneous treatment with PMA and BIM-1.
These results strongly suggest that the C-terminal region of
ATP11C is critical for PKC-induced endocytosis, and that the
decreases in PS/PE-ﬂippase activities can be attributed to
endocytosis of ATP11C and ATP11AAC by PKC activation.
We failed to examine ﬂippase activities affected by an increase in
cytosolic Ca2+; because Ca2+-dependent scramblase is activated
upon treatment of cells with A23187 in the presence of
extracellular CaCl234, NBD-phospholipids uptake displayed
by ﬂippases was not accurately measured. Flippase activities
toward PS and PE, but not PC, decreased upon treatment of
parental Ba/F3 cells with PMA (Fig. 5d–f, (−)), suggesting that
endocytosis of endogenous ATP11C might be responsible for the
decrease in PS/PE-ﬂipping activity. We previously showed that
ATP11C prefers PS to PE9; accordingly, the PMA-induced
inhibition of endogenous ﬂippase activity toward PE is milder
than that toward PS (Fig. 5d, e, (−)). A higher ﬂippase activity
toward PE was exhibited in cells expressing ATP11AAC and
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Fig. 4 C-terminus of ATP11C is indispensable for PMA-induced endocytosis. a Schematic structures of a chimeric construct of ATP11A and ATP11C proteins
are shown. b HeLa cells were transiently co-transfected with expression vectors for FLAG-tagged CDC50A and HA-tagged ATP11A, ATP11C, ATP11CAA,
ATP11ACC, ATP11AAC, or ATP11CCA. Cells were treated with vehicle alone (Mock) or 400 nM of PMA (PMA) for 15 min and ﬁxed. The ﬁxed cells were
permeabilized and incubated with anti-HA antibody, followed by Cy3-conjugated anti-rat secondary antibody. Scale bars, 20 μm
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(Fig. 5e), suggesting that the substrate preference of ATP11AAC
is similar to that of ATP11A.
Ser1116 is critical for PMA-induced endocytosis of ATP11C.
The C-terminal cytoplasmic region of ATP11C contains eight
serine residues (S1097, S1103, S1108, S1110, S1112, S1116, S1126,
and S1129) and one threonine residue (T1124), as shown in
Fig. 6a. Among the nine Ser/Thr residues, eight (with the
exception of S1097) are registered as phosphorylated sites in the
public phosphosite database (PhosphoSitePlus, http://www.
phosphosite.org/). Therefore, we investigated the possibility that
those Ser/Thr residues in C-terminal region of ATP11C partici-
pate in its endocytosis upon PKC activation. To this end, we
replaced each Ser/Thr residue with Ala, transiently expressed each
Ala mutant in HeLa cells, and observed protein localization fol-
lowing PMA treatment (Supplementary Fig. 3a). When Ser1116
was replaced with Ala (S1116A), PMA-induced internalization of
ATP11C was completely blocked (Supplementary Figs 3a and 6b).
Mutation of Ser1126 to Ala also inhibited PMA-induced endo-
cytosis, although some fraction of the protein was present in
intracellular endosomal structures (Supplementary Figs 3a and
6b). Mutants other than S1116A and S1126A were endocytosed as
efﬁciently as ATP11C(WT) upon PMA treatment (Supplemen-
tary Fig. 3a). These results suggest that Ser1116 and Ser1126 are
important for PMA-induced endocytosis of ATP11C, although
Ser1116 is more critical. Because Ser1116 and Ser1126 can be
phosphorylated52–54, we generated mutants in which Ser1116 or
Ser1126 was replaced with Asp to mimic the phosphorylated
state. Strikingly, the S1116D mutant localized to endosomal
compartments in the absence of PMA (Fig. 6b, upper panel of
S1116D and Supplementary Fig. 3b). These observations
demonstrate that phosphorylation at the Ser1116 residue is
indispensable for endocytosis of ATP11C, and suggest that this
phosphorylation might be mediated by PKC. Although mutation
of Ser1126 to Ala partially inhibited endocytosis (Fig. 6b),
mutation of Ser1126 to Asp did not affect the localization of
ATP11C in the absence of PMA (Fig. 6b, upper panel of S1126D),
suggesting that the phosphorylation of Ser1126 residue plays an
auxiliary role in PMA-induced ATP11C endocytosis.
Next, we asked whether phosphorylation of Ser1116 is solely
responsible for the PMA-induced endocytosis of ATP11C. To this
end, we generated four mutants by substituting Ala for all nine
Ser/Thr residues (9-Ala); eight residues, excluding Ser1116 or
Ser1126 (8-Ala(S1116) or 8-Ala(S1126), respectively); or seven
residues, excluding Ser1116 and Ser1126 [7-Ala(S1116/1126)]
(Fig. 6c). Upon PMA treatment, the 9-Ala and 8-Ala(S1126)
mutants of ATP11C were not internalized (Fig. 6c). By contrast,
8-Ala(S1116) was partially internalized and 7-Ala(S1116/1126)
internalized as efﬁciently as ATP11C(WT) (Fig. 6c). Therefore,
phosphorylation of Ser1116 is critical for PMA-induced endocy-

















































































































Fig. 5 C-terminus of ATP11C is required for inhibition of ﬂippase activities by PKC activation. a–c Ba/F3 cells stably expressing HA-tagged ATP11A,
ATP11C, and ATP11AAC chimeric proteins were treated with vehicle alone (a), 400 nM PMA (b), or 1 μM A23187 in the presence of CaCl2 (c) for 15min.
The cells were ﬁxed and immunostained with anti-HA and anti-ATP1A1 antibodies, followed by incubation with Cy3-conjugated anti-rat and Alexa Fluor
488-conjugated anti-rabbit secondary antibodies. Scale bars, 5 μm. d–f Ba/F3 cells were treated with vehicle alone (white bars), 400 nM PMA (black
bars), or 400 nM PMA and 2 μM of BIM-1 (gray bars) for 15 min. The cells were then washed with ﬂippase assay buffer and incubated at 15 °C for 5 min
with NBD-PS (d), or 15 min with NBD-PE (e) or NBD-PC (f). After extraction with fatty acid-free BSA, the residual ﬂuorescence intensity associated with
the cells was determined by ﬂow cytometry. Fold increase of NBD-lipids uptake is shown relative to that in Mock-treated parental Ba/F3 cells (−). Graphs
display averages from three independent experiments± SD. **p< 0.005; ***p< 0.001
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Phosphorylation of Ser1116 is required for ATP11C endocy-
tosis. In light of the potential phosphorylation of Ser1116 by
PKC, we noted that the pS1116VRPLL1120/1121 sequence (Fig. 6a)
in the C-terminal region of ATP11C is similar to the [DE]XXXL
[LI] (di-leucine) motif, which plays critical roles in intracellular
trafﬁcking and downregulation (endocytosis) of transmembrane
proteins, such as CD3, CD4, GLUT4, and ATP7A/B, a member of
the P-type ATPase superfamily43. To determine whether the
SVRPLL sequence of ATP11C serves as a di-leucine sorting motif,
we mutated Leu1120, Leu1121, or Leu1122 to Ala and observed
the localization of the mutant proteins in the presence or absence
of PMA (Fig. 6b). The L1120A and L1121A mutants remained
localized at the plasma membrane upon PMA treatment, whereas
the L1122A mutant was endocytosed as ATP11C(WT) (Fig. 6b),
indicating that Leu1120 and Leu1121, but not Leu1122, are cri-
tical for endocytosis. Therefore, PKC-induced endocytosis of
ATP11C requires phosphorylation of Ser1116 (act as an acidic
residue) and the di-leucine residues, Leu1120 and Leu1121.
To conﬁrm that the phospho-Ser1116-containing di-leucine
sequence (pSVRPLL) is sufﬁcient for endocytosis, we constructed
chimeric proteins possessing Lyn-EGFP (plasma membrane-
targeting signal of Lyn55 and EGFP, Fig. 7a), which is fused to the
C-terminal cytoplasmic region of ATP11C: CT-WT, CT-9-Ala
(9 Ser/Thr to Ala), CT-8-Ala-S1116 (8 Ser/Thr to Ala, except
Ser1116), and CT-8-Ala-S1126 (8 Ser/Thr to Ala, except Ser1126)
(Fig. 7b). All constructs localized to the plasma membrane in the
absence of PMA (Fig. 7Cc, Mock). Lyn-EGFP-CT-WT, but not
the original construct Lyn-EGFP-FRB (−), was internalized upon
treatment of cells with PMA, indicating that the C-terminal
region of ATP11C is sufﬁcient for PMA-induced endocytosis
(Fig. 7c, a middle panel). Lyn-EGFP-CT-WT was also inter-
nalized following an increase in cytosolic Ca2+ by A23187
treatment (Fig. 7c, a bottom panel). Importantly, the Lyn-EGFP-
CT-8-Ala-S1116 mutant was internalized as efﬁciently as Lyn-
EGFP-CT-WT upon PMA or A23187 treatment (Fig. 7c). By
contrast, the Lyn-EGFP-CT-9-Ala or Lyn-EGFP-CT-8-Ala-S1126
mutant was not internalized upon treatment of cells with either
PMA or A23187 (Fig. 7c), although the di-leucine residues
(Leu1120/1121) were present in these constructs (Fig. 7b). These
results demonstrate that the Ser1116 phosphorylation in the C-
terminal region of ATP11C by PKC creates a functional di-





















































Fig. 6 Ser1116, Leu1120, and Leu1121 serve as a di-leucine signaling motif upon PKC activation. a Alignment of amino acid sequences of the C-terminal
cytoplasmic region of mammalian ATP11C. Serine and threonine residues shown in bold were conserved among human (h), mouse (m), bovine (b), and dog
(d). Arrowheads exhibit critical residues for endocytosis, and the residue marked with an asterisk is involved in endosomal localization of ATP11C after PKC
activation. b HeLa cells were transiently co-transfected with expression vectors for FLAG-tagged CDC50A and HA-tagged WT of ATP11C, or mutants of
HA-tagged ATP11C, in which each bold residue in a was replaced with alanine (see also Supplementary Fig. 3a) or aspartate. c HeLa cells were transiently
co-transfected with expression vectors for FLAG-tagged CDC50A and HA-tagged WT of ATP11C, or mutants of HA-tagged ATP11C. In the mutants,
alanine replaced all serine and threonine residues in the C-terminus of ATP11C shown in a (9-Ala), all except Ser1116 (8-Ala(S1116)), all except Ser1126 (8-
Ala[S1126]), or all except Ser1116 and Ser1126 (7-Ala(S1116/1126)). b, c The cells were treated with vehicle alone (Mock) or 400 nM of PMA (PMA) for
15 min and ﬁxed. The ﬁxed cells were then incubated with anti-HA antibody, followed by incubation with Cy3-conjugated anti-rat secondary antibody. Scale
bars, 20 μm
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Regulation of ﬂippase activity of ATP11C in the plasma
membrane by endocytosis. Next, we examined the PS-ﬂippase
activity of endocytosis-defective ATP11C mutants (S1116A,
L1120A, and L1121A). To this end, we established Ba/F3 cells
stably expressing the mutants, as well as the L1122A mutant as a
negative control. Consistent with the results of transient expres-
sion in HeLa cells, the S1116A, L1120A, and L1121A mutants
were not endocytosed, whereas ATP11C(WT) and the L1122A
mutant were efﬁciently endocytosed upon PMA or A23187
treatment of Ba/F3 cells (Fig. 8a, b). We then assessed the cell-
surface level of ATP11C and its mutants, as well as ATP11A, by
surface biotinylation analysis. The cell surface levels of ATP11C
(WT) and the L1122A mutant on the cell surface decreased upon
PMA treatment, whereas those of endocytosis-defective mutants
did not substantially decrease (Fig. 8c, d), and the surface level of
ATP11A actually increased.
The PS-ﬂippase activities of cells stably expressing ATP11C
mutants was comparable to that of ATP11C(WT) under basal
conditions (Fig. 8e, white bars), indicating that these mutations
did not affect the enzymatic activity of ATP11C. Upon treatment
with PMA, uptake of NBD-PS was dramatically decreased in cells
expressing ATP11C(WT) and ATP11C(L1122A), but not in those
expressing ATP11A (Fig. 8e, black bars). Interestingly, cells
expressing endocytosis-defective mutants (S1116A, L1120A, and
L1121A) also exhibited reduced PS-ﬂippase activity to some
extent (Fig. 8e). When the ratio of PS-ﬂippase activities in the
presence vs. absence of PMA was estimated as shown in Fig. 8f,
the ratio was decreased by >50% in cells expressing ATP11C
(WT) and ATP11C(L1122A), and to a lesser extent in cells
expressing the endocytosis-defective mutants, S1116A, L1120A,
and L1121A. By contrast, the ratio was not signiﬁcantly altered in
ATP11A-expressing cells. To investigate the involvement of other
C-terminal phosphorylation sites of ATP11C in PS uptake, we
tested PS-ﬂippase activity in Ba/F3 cells stably expressing the
ATP11C(9-Ala) mutant (Fig. 8g); the ratio of the PS-ﬂippase
activities in the presence vs. absence of PMA is shown in Fig. 8h.
PS uptake was slightly inhibited by PMA treatment in cells
expressing the ATP11C(9-Ala) mutant, although to a greater
extent to that in cells expressing ATP11C(WT) (Fig. 8h). Taken
together, these ﬁndings indicate that sequestration of ATP11C
from the plasma membrane by endocytosis plays a role in the
efﬁcient down-regulation of the enzymatic activity of ATP11C,
although the activity might also be partially inhibited by PMA
treatment via an unknown mechanism.
Internalization of ATP11C is dependent on clathrin and
PKCα. Because the di-leucine motif is recognized by the clathrin
adaptor protein complex AP-244,56, we next asked whether
ATP11C endocytosis is mediated by a clathrin-dependent path-
way. To this end, we knocked down clathrin heavy chain by RNAi
in HeLa cells stably expressing ATP11C, and then treated the cells
with PMA or A23187 (Fig. 9). The efﬁcient depletion of clathrin
heavy chain was conﬁrmed by immunoblotting and immuno-
ﬂuorescence analyses (Supplementary Figs 4a and 9a, b, bottom
panels). Internalization of ATP11C induced by PMA or an
increase in cytosolic Ca2+ by A23187 treatment was dramatically
inhibited by depletion of clathrin heavy chain in comparison with
the control (Fig. 9b), indicating that ATP11C undergoes clathrin-
mediated endocytosis upon PKC activation. We classiﬁed and
counted cells with ATP11C only at the plasma membrane, both at
the plasma membrane and in intracellular compartments, and
only in intracellular compartments (Fig. 9d–f). In control cells,
ATP11C was endocytosed and did not appear at the plasma
membrane upon treatment of cells with PMA or A23187,
although endocytosis was induced less efﬁciently by A23187 than
PMA (Fig. 9d). By contrast, in cells depleted of clathrin heavy
chain, ATP11C mostly remained at the plasma membrane upon
PMA or A23187 treatment (Fig. 9b, e). These results indicate that
ATP11C is internalized by clathrin-mediated endocytosis, prob-
ably via its interaction with AP-2 through the di-leucine motif,
which is generated by signal-dependent phosphorylation of
Ser1116.
We then sought to determine which PKC isoform is involved
in the ATP11C internalization. To address this question, we
knocked down various PKC isoforms (Supplementary Fig. 4b, d)
by RNAi. Because the signal-dependent endocytosis of ATP11C
was Ca2+-dependent, we speculated that cPKC (α, β, and γ) might
be involved. However, we knocked down not only cPKC (PKCα,
and β) but also PKCδ, ε, and ζ (Supplementary Fig. 4b, d); we did
not include PKCγ in this experiment because it is speciﬁcally
expressed in central nervous system. Furthermore, PKCβ was not
expressed in HeLa cells, as determined by RT-PCR analysis
(Supplementary Fig. 4c). Therefore, only the PKCα isoform
among cPKC is expressed in HeLa cells. As shown in
Supplementary Fig. 4d, Fig. 9c, f, depletion of PKCα, but not
other isoforms, inhibited the internalization of ATP11C upon
treatment of cells with A23187. However, knockdown of PKCα
did not inhibit the ATP11C internalization in response to PMA


























Fig. 7 Phosphorylation of Ser1116 containing the Leu1120/Leu1121
(pSVRPLL) motif is sufﬁcient for endocytosis. a Schematic representation of
chimeric protein. The plasma membrane targeting signal of Lyn and EGFP
was fused to the C-terminal cytoplasmic region (CT) of ATP11C. b Amino
acid sequences in the C-terminal cytoplasmic region (CT) of human
ATP11C, which were fused to Lyn-EGFP as shown in a. c HeLa cells
were transiently transfected with expression vector for Lyn-EGFP-tagged
CT-WT, CT-9-Ala, CT-8-Ala/S1116, or CT-8-Ala/S1126, or the original
vector encoding Lyn-EGFP-tagged FRB (FKBP–rapamycin-binding domain).
The cells were treated for 15 min with vehicle alone (Mock), 400 nM PMA
(PMA), or 1 μM A23187 in the presence of 1.8 mM CaCl2 (A23187),
followed by ﬁxation. Scale bars, 20 μm
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activator, residual PKCα might facilitate the ATP11C internaliza-
tion. Taken together, these observations indicate that the
Ca2+-dependent endocytosis of ATP11C is mediated by PKCα
activation.
ATP11C is internalized by stimulation of Gq-coupled receptor.
Next, we asked whether the internalization of ATP11C takes place
under physiologically relevant conditions. Firstly, we established
HeLa cells stably co-expressing Gq-coupled serotonin receptor
(5-hydroxytryptamine (HT) receptor 2A; 5-HT2A-R) and
ATP11C-HA (Fig. 10c, d). Stimulation of Gq-coupled receptors
activates phospholipase C, which catalyzes hydrolysis of phos-
phatidylinositol 4,5-bisphosphate to inositol 1,4,5-trisphosphate
(IP3) and diacylglycerol (DAG). IP3 triggers the release of Ca2+
from intracellular stores and PKC is activated by cytosolic Ca2+
and DAG (Supplementary Fig. 6). As shown in Fig. 10c, ATP11C
was internalized following treatment of the cells co-expressing
5-HT2A-R and ATP11C with serotonin (5-HT) for 10 min, but
not in cells expressing ATP11C alone (Fig. 10a), indicating that
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endocytosis. To conﬁrm that 5-HT2A-R-mediated Ca2+ signaling
gives rise to the ATP11C endocytosis, we observed the ATP11C
endocytosis in cells treated with BAPTA-AM to chelate cytosolic
Ca2+. As shown in Supplementary Fig. 5a, the endocytosis of
ATP11C induced by 5-HT treatment was dramatically inhibited
by pretreatment of cells with BAPTA-AM, demonstrating that the
ATP11C endocytosis is elicited by an increase in the cytosolic
Ca2+ level in response to 5-HT. The ATP11C endocytosis
induced by 5-HT treatment also occurred in cells stably
co-expressing C-terminally FLAG-tagged 5-HT2A-R and
ATP11C-HA (Supplementary Fig. 5b, c). It is noteworthy that the
FLAG-tagged 5-HT2A-R was also endocytosed57 and colocalized
with ATP11C upon 5-HT treatment (Supplementary Fig. 5).
Internalized ATP11C was colocalized with EEA1 but not with
Lamp-1 (Fig. 10c, enlarged panels), consistent with the results
shown in Fig. 3. Furthermore, when the cells washed and replaced
with 5-HT-free medium, endosomal ATP11C disappeared and
the plasma membrane localization of ATP11C was restored
(Fig. 10d). When the cells were classiﬁed into those with ATP11C
only at the plasma membrane and those in intracellular com-
partments as well as at the plasma membrane (endocytosed)
(Fig. 10b, e), the population of cells with endosomal ATP11C was
dramatically increased upon 5-HT treatment for 10 min, while
removal of 5-HT caused return of ATP11C to the plasma
membrane (Fig. 10e) probably due to a reduction in the cytosolic
Ca2+ level. The 5-HT-induced ATP11C internalization was not
observed in control cells, which did not express exogenous
5-HT2A-R (Fig. 10b). Recycling of ATP11C probably requires
SNX27 and Vps35, a component of the retromer complex58;
consistent with the observation, when cells were treated with
PMA or A23187, internalized ATP11C was extensively coloca-
lized with Vps35 (Fig. 2b, c, enlarged insets). We then visualized
the endocytosis of EGFP-tagged ATP11C in cells expressing
5-HT2A-R by time-lapse imaging analysis (Supplementary
Movie 2). EGFP-ATP11C was localized to the plasma membrane
just after serum starvation, and rapidly internalized and accu-
mulated to endosomal compartments upon 5-HT treatment
(Supplementary Movie 2). We also investigated the ATP11C
endocytosis via Ca2+ signaling mediated by an endogenous Gq-
coupled receptor. HeLa cells are known to undergo Ca2+ signaling
upon stimulation with histamine via Gq-coupled histamine H1
receptor (H1-R)59–61. ATP11C was internalized following treat-
ment of cells with histamine for 10 min (Fig. 10f), although to a
lesser extent compared with that induced by PMA or A23187
treatment, indicating that Ca2+ signaling via endogenous H1-R
induced the ATP11C endocytosis. Internalized ATP11C was
colocalized with EEA1 but not with Lamp-1 (Fig. 10f, enlarged
panels), consistent with the results shown in Figs. 3 and 10c.
When the cells were classiﬁed into those with ATP11C only at the
plasma membrane and those in intracellular compartments as
well as at the plasma membrane (endocytosed) (Fig. 10g), the
endosomal ATP11C level was increased upon treatment of cells
with histamine for 10 min, while a longer histamine treatment
(60 min) causes return of ATP11C to the plasma membrane
(Fig. 10f, g), consistent with the results shown in Fig. 10d.
Discussion
In this study, we demonstrated that internalization of ATP11C is
induced by Ca2+-dependent PKCα activation, and revealed that
phosphorylation of Ser1116 in the C-terminal cytoplasmic region
of ATP11C results in generation of a functional di-leucine motif
(pSVRPLL) required for endocytosis. Furthermore, the ATP11C
internalization is mediated by clathrin-dependent endocytosis,
and is responsible for the decrease in the PS-ﬂipping activity at
the plasma membrane. 5-HT2A-R and H1-R (Gq-coupled
receptors)-mediated Ca2+ signaling enabled the endocytosis of
ATP11C, and thus the signal-dependent endocytosis of ATP11C
constitutes an important physiological mechanism for regulation
of local asymmetrical PS distribution in the plasma membrane
(Supplementary Fig. 6). Downregulation of ATP11C and activa-
tion of Ca2+-dependent scramblase may enable cell-surface
exposure of PS at speciﬁc times and places (Supplementary
Fig. 6). The mechanism of ATP11C downregulation seems to be
conserved in adherent (HeLa) and non-adherent (pro-B cell line
Ba/F3) cells. Since ATP11C deﬁciency causes a defect in B-cell
maturation, altered erythrocyte shape and anemia25,26,62, it is
tempting to speculate that PKC-mediated regulatory mechanism
of ATP11C contributes to B-cell differentiation or erythrocyte
homeostasis.
It is noteworthy that knockout of ATP11C does not result in
the cell surface exposure of PS (our unpublished data)23, although
ﬂippase activity toward NBD-PS is dramatically decreased.
Contrary to knockout of ATP11C, that of CDC50A leads to PS
exposure (our unpublished data)23, indicating that global asym-
metric transbilayer distribution of PS could be maintained by
multiple PS-speciﬁc P4-ATPases. Moreover, there might be
another compensatory mechanism to prevent PS-exposure. In
fact, upon treatment of cells with PMA, the surface level of
ATP11A was increased (Figs. 1b and 8c), and may compensate
for PMA-induced inhibition of PS-ﬂippase activity of ATP11C,
although we do not know the mechanism and physiological
relevance of the alteration of ATP11A level.
The AP-2 adaptor complex (composed of α, β2, μ2,
and σ2 subunits) recognizes two distinct endocytic motifs, YXXΦ
(Φ stands for a bulky hydrophobic residue) and [DE]XXXL[LI].
Fig. 8 Flippase activity of ATP11C inhibited by PKC is partially rescued by endocytosis-defective mutants. a–d Ba/F3 cells stably expressing the indicated
point mutants of ATP11C-HA were treated with vehicle alone (Mock), 400 nM PMA (PMA), or 1 μM A23187 in the presence of CaCl2 (A23187) for 15min.
a Cells were immunostained with anti-HA and anti-ATP1A1 antibodies, followed by incubation with Cy3-conjugated anti-rat and Alexa Fluor 488-
conjugated anti-rabbit secondary antibodies. Scale bars, 20 μm. b The cells with ATP11C mutants localized to the plasma membrane (PM), to the plasma
membrane and endosomes (PM + E), or to the endosomes (E) were counted; counts were normalized against the total number of counted cells. In each
sample, 315–459 cells were counted. Graphs display averages± SD from three independent experiments. c Cell-surface expression level of ATP11A,
ATP11C, and the indicated mutants upon treatment with PMA were analyzed after surface biotinylation. Proteins precipitated with streptavidin-agarose
beads were subjected to immunoblot analysis (upper panels, biotinylated). Ten percent of the input of the biotinylation reaction was loaded in each lane
(lower panels, total lysate). Expression levels of P4-ATPases were analyzed by immunoblotting with anti-HA and anti-ATP1A1 (as an internal control)
antibodies. d Relative surface expression levels of proteins, normalized against the level of ATP1A1 (used as an internal control). Graphs display averages±
SD from four independent experiments. **p< 0.005; ***p< 0.001. e, g Ba/F3 cells stably expressing ATP11A, ATP11C, the indicated point mutant of
ATP11C, or ATP11C(9-Ala) were treated with vehicle alone (white bars) or 400 nM PMA (black bars) for 15min. The cells were then washed with ﬂippase
assay buffer and incubated with NBD-PS at 15 °C for 5 min. After extraction with fatty acid-free BSA, the residual ﬂuorescence intensity associated with the
cells was determined by ﬂow cytometry. Fold increase in NBD-PS uptake is shown relative to that in parental Ba/F3 cells (−). Graphs display averages± SD
from four (e) or three (g) independent experiments. f, h Ratio of PS-ﬂip activity in PMA vs. mock-treated cells in e and g, respectively. Graphs display
averages± SD from four f or three h independent experiments. *p< 0.01; **p< 0.005; ***p< 0.001
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The former tyrosine-containing motif binds to the binding pocket
of μ2, whereas the latter di-leucine motif binds to that formed by
α and σ244. The YXXΦ and [DE]XXXL[LI] signals play critical
roles in the sorting of many transmembrane proteins: CI-MPR,
furin, TGN46, CD63, and Lamp-1 contain the YXXΦ motif; and
GLUT4, CD3, CD4, and ATP7A/B (a Cu+ transporter) contain
the [DE]XXXL[LI] motif43. T-cell receptor and the T-cell surface
antigen CD4 are internalized from the plasma membrane via
clathrin-mediated endocytosis after PKC-mediated receptor
phosphorylation63,64. CD4 undergoes a similar downregulation
upon phosphorylation of a serine residue within its SQIKRLL
(SQXXXLL) sequence, although it contains Q instead of D/E at
the –4 position from the di-leucine residues65. The DKQTLL
(DXXXLL) sequence of CD3γ, a T-cell receptor (TCR) subunit, is
part of an adjustable SDKQTLL signal that participates in serine
phosphorylation-dependent downregulation of the TCR from the
cell surface64. Interestingly, ATP11C contains a SVRPLL
sequence in its C-terminal cytoplasmic region that cannot serve
as an endocytic signal unless the Ser residue is phosphorylated in
response to cellular signals. Thus, endocytosis of ATP11C is
tightly regulated, which is reasonably given that ATP11C plays an
important role in maintaining asymmetric PS distribution at the
plasma membrane19,23,22. On the other hand, PMA-treatment
slightly decreased the ﬂippase activity of ATP11C(9-Ala)
(Fig. 8g), suggesting that the ATP11C activity, regardless of its
endocytosis, could be marginally inhibited. Phosphorylation of
ATP11C besides its C-terminal region, or interaction of ATP11C
with other phosphorylated proteins might contribute to the
inhibition. Although ATP11A also contains a STIFML sequence,
which is similar to dileucine-based signals, in its C-terminal
cytoplasmic region (Supplementary Fig. 2), it could not serve as
the endocytic signal at least by Ca2+-mediated PKC activation.
ATP11C may cycle between the plasma membrane and
endosomes, because its cell-surface expression is reduced in
SNX27- or VPS35-depleted cells58. Thus, SNX27 and the retro-
mer complex regulate the recycling pathway of ATP11C from
endosomes to the plasma membrane. When cells are exposed to a
receptor-mediated signal leading to PKC activation, phosphor-
ylation of ATP11C allows its removal from the plasma mem-
brane, which may contribute to the disruption of asymmetric PS
distribution in the plasma membrane. Internalized ATP11C is not
transported to lysosomes for degradation (Fig. 3), suggesting that
it may be recycled back to the plasma membrane soon after
termination of signaling, thus contributing to homeostasis of PS
distribution at the plasma membrane. Indeed, treatment of cells
with 5-HT or histamine once causes internalization of ATP11C,
and further incubation restores the plasma membrane localiza-
tion of ATP11C (Fig. 10). When and where is signal-dependent
downregulation of ATP11C required? Spatiotemporally regulated
PS exposure occurs not only in cells fated for elimination, such as
platelets and apoptotic cells, but also in living cells, such as
activated immune cells, capacitated sperm cells, and mast and
neuroendocrine cells during signal-dependent
exocytosis31–33,45,66–68. Therefore, signal-dependent down-
regulation of ATP11C might participate in temporal redistribu-
tion of PS at the plasma membrane (Supplementary Fig. 6).
Because apoptotic cells do not need to restore asymmetric dis-
tribution of PS, ATP11A and ATP11C are cleaved by caspases,
concomitant with activation of the phospholipid scrambling23,69.





































































Fig. 9 ATP11C is downregulated by clathrin-mediated endocytosis upon PKC activation. HeLa cells stably expressing ATP11C-HA were transfected with
non-targeting siRNA (siControl) (a, d) or siRNAs against clathrin heavy chain (CHC) (b, e) or PKCα (c, f). (see Supplementary Fig. 4). Each siRNA-treated
sample was treated with vehicle alone (Mock), 400 nM PMA (PMA), or 1 μM A23187 in the presence of CaCl2 (A23187) for 15 min, followed by ﬁxation.
The ﬁxed cells were permeabilized and incubated with anti-HA, anti-ATP1A1, and anti-CHC antibodies, followed by Cy3-conjugated anti-rat, Alexa Fluor
647-conjugated anti-rabbit, and Alexa Fluor 488-conjugated anti-mouse secondary antibodies. Scale bars, 20 μm. d–f The cells in which ATP11C localized
to the plasma membrane (PM), to the plasma membrane and endosomes (PM + E), or to endosomes (E) were counted; counts were normalized against
the total number of counted cells. In each sample, 643–783 cells were counted. Graphs display averages± SD from three independent experiments
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addition to activities of scramblases? Although the activation of
scramblases might be enough for initial PS exposure, stable PS
exposure for further cellular functions and/or PS-selectivity
would be attributed to the inhibition of ATP11C since scram-
blases do not seem to have a substrate speciﬁcity39. Notably,
during apoptosis induction, caspase-resistant ATP11C did not
allow PS exposure, suggesting that inhibition of ﬂippase as well as
activation of scramblase is most likely required for PS
exposure4,23,70.
Recent studies have suggested that choleretic and cholestatic
effects may be mediated by PKC isoforms71. PKCα mediates
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Fig. 10 ATP11C is endocytosed by treatment with serotonin or histamine. a–e HeLa cells stably expressing C-terminally HA-tagged ATP11C alone (a, b) or
ATP11C-HA and untagged 5-HT2A-R (c–e) were serum starved for 3 h and treated with 500 nM 5-HT for indicated times c. See Supplementary Movie 2.
After 30min treatment, cells were washed with 5-HT-free medium and incubated in the medium for indicated times (d). f, g HeLa cells stably expressing
C-terminally HA-tagged ATP11C were treated with vehicle alone (Mock) or 5 μM of histamine for indicated times. The cells were ﬁxed and doubly stained
for HA, and EEA1 or Lamp-1 followed by incubation with Cy3-conjugated anti-rat and Alexa Fluor 488-conjugated anti-mouse secondary antibodies (f).
Images were obtained by confocal microscopy. Scale bars, 20 μm. Insets are enlarged (bars, 2 μm). b, e, g Cells in which ATP11C localized to the plasma
membrane (PM), or to the plasma membrane and endosomes (endocytosed) were counted; counts were normalized against the total number of counted
cells. In each sample, 370–1273 cells were counted. Graphs display averages± SD from four (b, e) or three (g) independent experiments
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by PMA72, and PKCδ mediates the cAMP-induced translocation
of sodium–taurocholate co-transporting polypeptide (NTCP) and
multidrug resistance-associated protein 2 (MRP2) to the plasma
membrane in rat hepatocytes73. ATP11C deﬁciency causes
hyperbilirubinemia and hypercholanemia in mice27, and ATP11C
appears to be involved in transport of bile acids across the
sinusoidal membrane74,75. Therefore, ATP11C might be impor-
tant for the regulation of bile acid transporters in the sinusoidal
membrane of hepatocytes. PKC isoform-speciﬁc signaling may
regulate not only BSEP and MRP2 in the canalicular membrane,
but also ATP11C and NTCP in the sinusoidal membrane, to exert
a choleretic effect.
Methods
Plasmids. Expression vectors for C-terminally HA-tagged human P4-ATPases
were constructed as described previously9,10. An expression vector for N-terminally
EGFP-tagged ATP11C was constructed by subcloning a cDNA fragment con-
taining the entire coding sequence of human ATP11C into pEGFP-C1 (Invitrogen)
or pCAG-EGFP. To construct pCAG-EGFP, DNA fragment encoding EGFP was
ampliﬁed from pEGFP-C1 and inserted into pCAG vector. Chimeric ATP11A with
the N- or C-terminal cytoplasmic region from ATP11C and chimeric ATP11C with
the N- or C-terminal cytoplasmic region from ATP11A were constructed using
PCR and the In-Fusion HD cloning kit (Clontech). Point mutations of ATP11C
were introduced into the ATP11C cDNA using the QuikChange II XL site-directed
mutagenesis kit (Agilent Technologies). For construction of ATP11C(9-Ala),
ATP11C(8-Ala(S1116)), and ATP11C(8-Ala(S1126)), DNA fragments encoding
the C-terminal region of ATP11C with the indicated mutations (135 base pairs)
were synthesized (Thermo Fisher Scientiﬁc) and inserted to replace the same
region of WT ATP11C cDNA using the SLiCE cloning method76. For construction
of ATP11C(7-Ala(S1116/S1126), a point mutation (Ala1126 to Ser) was introduced
into the ATP11C(8Ala(S1116)) cDNA using the QuikChange II XL site-directed
mutagenesis kit. Lyn-EGFP-FRB (FKBP–rapamycin-binding domain) construct55
was a kind gift from Takanari Inoue (Johns Hopkins University). For construction
of Lyn-EGFP-fused chimeras, DNA fragments encoding the C-terminal region of
ATP11C (WT, 9-Ala, 8-Ala(S1116), and 8-Ala(S1126)])were ampliﬁed by PCR and
inserted to replace the FRB cDNA using BsrGI and XhoI sites. Oligos are listed in
Supplementary Table 1. Mouse 5-HT2A receptor cDNA was obtained from mouse
(C57BL/6) brain total RNA by RT-PCR using Superscript III First-Strand
Synthesis System (Invitrogen) and KOD FX Neo DNA polymerase (Toyobo).
The following primer pairs were used: forward, 5′-GCCGGATCCACCATG-
GAAATTCTCTGTGAAGACAATATCTC-3′, and reverse, 5′-CGCGTCGACT-
CACACACACGTAACCTTTTCATTCACGG-3′ or 5′-CGCGTCGACACAC
ACGTAACCTTTTCATTCACGG (for C-3′-terminal tagging). 5-HT2A receptor
cDNA was inserted into the pENTR3C vector (Invitrogen). Transfer of the cDNA
to pMXs-puro-DEST-FLAG was performed using Gateway system (Invitrogen).
Antibodies and reagents. Sources of antibodies used in this study were as follows:
monoclonal rabbit anti-ATP1A1 (EP1845Y), Abcam; monoclonal mouse anti-
EEA1 (clone14), anti-Lamp1 (H4A3), and anti-clathrin heavy chain (clone23), BD
Biosciences; monoclonal mouse anti-TfnR (H68. 4), Zymed; monoclonal mouse
anti-clathrin heavy chain (X22), Thermo Fisher Scientiﬁc; monoclonal mouse anti-
β-tubulin (KMX-1), Millipore; polyclonal rabbit anti-TGN46, kind gift from
Minoru Fukuda (Burnham Institute); polyclonal goat anti-VPS35, IMGENEX;
monoclonal rat anti-HA (3F10), Roche Applied Science; Alexa Fluor-conjugated
secondary antibodies, Invitrogen; Cy3- and horseradish peroxidase-conjugated
secondary antibodies, Jackson ImmunoResearch Laboratories (Supplementary





phosphocholine). The calcium ionophore A23187, phorbol 12-myristate 13-acetate
(PMA), and bisindolylmaleimide I (BIM-1) were purchased from Cayman Che-
mical, LC Laboratories, and Santa Cruz Biotechnology, respectively. 5-hydro-
xytryptamine, histamine, and BAPTA-AM were purchased from Nacalai Tesque.
Cell culture and establishment of stable cell lines. The interleukin (IL-3)-
dependent murine pro-B cell line Ba/F3 and cells expressing recombinant mouse
IL-3 were kind gifts from Shigekazu Nagata (Osaka University). The Ba/F3 cells
were maintained in RPMI-1640 medium containing 10% fetal calf serum, as
described previously77. HeLa cells were cultured as described previously10. Ba/F3
and HeLa cells expressing each C-terminally HA-tagged P4-ATPase were estab-
lished as described previously9. To transiently express P4-ATPases, HeLa cells were
transfected with a pCAG-HA-based vector carrying P4-ATPase cDNA (C-term-
inally HA-tagged) or pCAG-EGFP containing the ATP11C cDNA (N-terminally
EGFP-tagged) and a pcDNA3-FLAG-based vector containing CDC50A cDNA10.
Transfections were performed by lipofection using X-tremeGENE9 (Roche Applied
Science). One or two days later, the transfected cells were ﬁxed for immuno-
ﬂuorescence analysis. The establishment of HeLa cells co-expressing either
untagged 5-HT2A-R or C-terminally FLAG-tagged 5HT2A-R and ATP11C-HA,
recombinant retrovirus for expression of 5-HT2A-R or 5-HT2A-R-FLAG was
produced and used to infect ATP11C-HA-expressing HeLa cells9. The infected cells
were selected in medium containing puromycin (1 μg ml−1). A mixed population of
drug resistant cells was used for immunoﬂuorescence analysis.
Immunoﬂuorescence analysis and time-lapse imaging analysis. Immunos-
taining was performed as described previously78 and visualized using an Axiovert
200MAT microscope (Carl Zeiss) and an A1R-MP confocal laser-scanning
microscope (Nikon). For time-lapse recording, EGFP-ATP11C expressing HeLa
cells were placed on a microscope stage prewarmed to 37 °C, and then observed on
an A1R-MP confocal microscope. After 5 min recording, PMA was administered,
and images were recorded every 7.8 s for a total of 34 min (Supplementary
Movie 1). For Supplementary Movie 2, the cells were incubated in serum-free
medium containing 2% BSA for 3 h. After 5 min recording, 5-HT was administered
and images were recorded every 8.0 s for a total 79 min.
RNA interference. Knockdown of clathrin heavy chain (CHC) or individual PKC
isoforms was performed as described previously14,79. siRNA oligonucleotides were
synthesized by Sigma Genosys as described previously for CHC80, PKCα81, and
PKCβ, PKCδ, PKCε, and PKCζ82. Control siRNA was purchased from Dharma-
con. The cells were transfected with siRNAs using Lipofectamine 2000 (Invitrogen)
and incubated for 24 h. The transfected cells were then transferred to a culture dish
containing coverslips, incubated for an additional 48 h, and processed for immu-
noﬂuorescence, immunoblot analyses, and RT-PCR analyses as described
previously14,20.
RT-PCR. Total RNA was extracted from cells using the RNeasy kit (Qiagen) and
subjected to RT-PCR analysis using the SuperScript III One-Step RT-PCR system
(Invitrogen). Fragments of PKC isoforms were ampliﬁed using the following
primer pairs: PKCαː forward, 5′-GGCCAGTGGATGGTACAAGTTG-3′, reverse,
5′-CTGTCGGCAAGCATCACCTTTC-3′;
PKCβ I and II: forward, 5′-GAAAGCCAGTGTTGATGGCTG-3′, reverse, 5′-
GCCTTTTCGTTCTGAAAGCATG-3′; PKCδː forward, 5′-GTGAAGACTGC
GGCATGAATG-3′, reverse, 5′-CAAGCAGCACCTTCCCGAAG; PKCε−3′;
forward, 5′-CGAGGACTGGATTGATCTGGAG-3′, reverse, 5′-CAGGTGCAGA
CTTGACACTGG-3′; PKCζ: forward, 5′-CAGGAGAGCGTACTGCGGTC-3′,
reverse, 5′-CTGGCTTAAGGTCCTCCGAG-3′.
Surface biotinylation. Cell-surface biotinylation assay was performed as described
previously83. Brieﬂy, cells were washed three times with chilled PBS containing
0.1 mM CaCl2 and 0.1 mM MgCl2 (PBS++), and then incubated at 4 °C for 30 min
with 2 mM sulfo-NHS-LC-biotin (Thermo Scientiﬁc) in PBS++. To stop biotiny-
lation, the cells were washed three times with chilled PBS++ containing 100 mM
glycine and 0.3% BSA, and then washed twice more with chilled PBS. The cells
were then lysed in lysis buffer (20 mM HEPES-KOH (pH 7.4) containing 1% NP-
40, 150 mM NaCl, and protease inhibitor mixture (Complete, Roche Applied
Science) for 30 min at 4 °C. The lysates were centrifuged at maximum speed at 4 °C
for 20 min in a microcentrifuge to remove cellular debris and insoluble materials.
To precipitate the biotinylated proteins, the supernatant was incubated at 4 °C for
4 h with streptavidin-agarose beads (Thermo Scientiﬁc) pre-equilibrated with lysis
buffer. The protein-bound streptavidin beads were washed three times with lysis
buffer, twice with high-salt buffer (20 mM HEPES-KOH (pH 7.4), 500 mM NaCl,
1 mM EDTA, 0.5% NP-40), and once with 20 mM HEPES-KOH, pH 7.4. Proteins
were eluted from the beads with SDS-PAGE sample buffer, denatured at 37 °C for
2 h, and subjected to immunoblot analysis.
Flippase assay. Incorporation of NBD-phospholipids was analyzed by ﬂow
cytometry as described9. In brief, HeLa cells were detached from dishes in PBS
containing 5 mM EDTA, and then collected by centrifugation. Ba/F3 cells were
collected from suspension culture by centrifugation. Cells (2 × 105 cells per sample)
were washed and equilibrated at 15 °C for 30 min in 100 μl of Hank’s balanced salt
solution (pH 7.4) containing 1 g/l glucose (HBSS-glucose). An equal volume of
2 μM NBD-phospholipid in HBSS-glucose was added to the cell suspension and
incubated at 15 °C. At each time point, 200 μl of the cell suspension was mixed with
200 μl of ice-cold HBSS-glucose containing 5% fatty acid-free BSA (Wako) to
extract NBD-lipids incorporated into the exoplasmic leaﬂet of the plasma mem-
brane, as well as unincorporated lipids. Next, the cells were analyzed with a
FACSCalibur (BD Biosciences) to measure ﬂuorescence of NBD-lipids incorpo-
rated and translocated into the cytoplasmic leaﬂet of the plasma membrane.
Graphs for NBD-lipid ﬂippase activities are expressed as averages± SD from at
least three independent experiments.
Data availability. The data supporting the ﬁndings of this study are available
within the article and its Supplementary Information ﬁles, and are available from
the corresponding author upon request.
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